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Abstract. Nucleotide excision repair (NER) is a highly versatile and efficient DNA repair process, which is responsible for the removal of a large
number of structurally diverse DNA lesions. Its extreme broad substrate specificity ranges from DNA damages formed upon exposure to
ultraviolet radiation to numerous bulky DNA adducts induced by mutagenic environmental chemicals and cytotoxic drugs used in chemo-
therapy. Defective NER leads to serious diseases, such as xeroderma pigmentosum (XP). Eight XP complementation groups are known of
which seven (XPA–XPG) are caused by mutations in genes involved in the NER process. The eighth gene, XPV, codes for the DNA polymerase
ɳ, which replicates through DNA lesions in a process called translesion synthesis (TLS). Over the past decade, detailed structural information of
these DNA repair proteins involved in eukaryotic NER and TLS have emerged. These structures allow us now to understand the molecular
mechanism of the NER and TLS processes in quite some detail and we have begun to understand the broad substrate specificity of NER. In
this review, we aim to highlight recent advances in the process of damage recognition and repair as well as damage tolerance by the XP proteins.
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The DNA is attacked daily by ultraviolet (UV) radiation, chemical carcinogens, cellular metabolites as well as anti-cancer
drugs such as cisplatin (Hoeijmakers, 2001) leading to more than 50 000 damages per cell per day (Rajski et al. 2000). To
preserve the integrity of the genetic information, all organisms are equipped with a number of DNA repair or tolerance
mechanisms such as DNA recombination, base excision repair (BER), mismatch repair (MMR), nucleotide excision repair
(NER) and translesion synthesis (TLS) that allow cells to cope with the different lesions (Friedberg, 2005; Ohmori et al.
2001; Rupp & Howard-Flanders, 1968). In this review, we will focus on eukaryotic NER and TLS.
1.2 NER and NER-related diseases
One of the most prominent processes among the DNA repair pathways is the NER. NER is a central pathway safeguarding the
genome and cells against induced carcinogenesis, because of its capacity to eliminate a broad range of structurally very dif-
ferent DNA lesions (de Laat et al. 1999; Geacintov et al. 2002; Gillet & Scharer, 2006; Gunz et al. 1996; Huang et al. 1994)
including UV lesions such as cyclobutane–pyrimidine dimers (CPDs) and 6–4 pyrimidine–pyrimidone photoproducts
(6-4PPs), numerous bulky chemical adducts, intrastrand crosslinks caused by chemotherapeutics such as cisplatin and oxi-
dative damages (Fig. 1) (Brooks et al. 2000; Demple & Harrison, 1994). All these lesions do not share the same chemical
structures, but they are bulky and they thermodynamically destabilize the DNA helix, except for CPDs.
In humans, mutations of NER components lead to three severe diseases: xeroderma pigmentosum (XP), Cockayne syndrome
(CS) and trichothiodystrophy (TTD) (Cleaver, 2000; Lehmann, 2001). The NER pathway is divided in two subpathways: the
global genome NER (GG-NER) and the transcription-coupled NER (TC-NER) (Gillet & Scharer, 2006; Hanawalt & Spivak,
2008) differing only in their damage recognition step. But NER in chromatin is a complex process and probably uses the
proposed ‘access–repair–restore’ mechanism, which comprises many components (Scharer, 2013). A defect in TC-NER
along with a mild transcription effect can cause CS and TTD (Cleaver et al. 2009).
The CS is characterized by developmental impairment, premature aging and sunlight sensitivity. TTD leads to developmental
impairment and mental retardation without showing skin cancer predisposition (Cleaver et al. 2009; Lehmann, 2003).
Mutations inactivating the GG-NER cause the genetic disorder XP (Cleaver et al. 2009). Persons affected by XP (‘children
of the moon’) need to avoid exposure to sunlight, because they show a high predisposition to UV-induced skin cancer
(Berneburg & Lehmann, 2001; Hebra & Kaposi, 1874; Lehmann, 2003). Seven complementation groups (XPA–XPG)
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associated with different NER gene defects were discovered by cell fusion techniques (De Weerd-Kastelein et al. 1972). The
discovery of NER and its association with genetic disorders together with the mechanism of action have already been reviewed
(Friedberg, 1995). Mutations associated with XP and posttranslational modifications of the XP proteins have also been re-
cently reported (Feltes & Bonatto, 2015). The variant form of the human syndrome xeroderma pigmentosum (XPV)
(Masutani et al. 1999b) is caused by a defect in DNA polymerase ɳ. In this paper, we review the eukaryotic structures of
XP proteins (XPA–XPG), including the XP variant DNA polymerase ɳ (called XPV) in complex with damaged or undamaged
DNA. This review will provide insights at the atomic level of how lesions in DNA are processed by these proteins.
1.3 NER mechanism
With the exception of chromatin, the NER mechanism is well understood in Escherichia coli as well as in eukaryotes (Naegeli
& Sugasawa, 2011; Sancar & Tang, 1993; Scharer, 2013). While the repair process in eukaryotes is accomplished by up to 30
Fig. 1. Examples of DNA adducts repaired by NER. AAF-dG: N-(2′-desoxyguanosin-8-yl)-2-acetylaminofluorene, AF-dG:
N-(2′-desoxyguanosin-8-yl)-2-aminofluorene AAP-dG: N-(2′-desoxyguanosin-8-yl)-2-acetylaminopyrene 6–4PP: 6–4PP, CPD: cyclobu-
tane–pyrimidine dimer, 1,2-GG and 1,3-GTG: major cisplatin-induced intrastrand crosslinks lesions.
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proteins, the precise role of each protein has not been fully elucidated so far. Despite this, a general core repair mechanism has
emerged (Fig. 2). In eukaryotes, the NER is divided in two distinct subpathways differing only in their damage recognition
step (de Laat et al. 1999; Hanawalt & Spivak, 2008; Mellon et al. 1987). TC-NER ensures the repair of lesions which are located
on the transcribed strand of active genes (Hanawalt & Spivak, 2008; Hoeijmakers, 2001; Mellon et al. 1987; Sweder &
Hanawalt, 1992). Here the RNA-polymerase II seems to act as the initial damage sensor. During transcription the polymerase
gets stalled at the lesion site (Donahue et al. 1994; Tornaletti & Hanawalt, 1999) and by addition of the protein Cockayne
syndrome group B (CSB) a stable CSB–RNAP–DNA complex can from by ATP-hydrolysis (Citterio et al. 2000; Tantin
et al. 1997). In case the lesion blocks any read through, downstream factors such as Cockayne syndrome group A protein
(CSA) (Kamiuchi et al. 2002), TFIIH (Tantin, 1998) and XPG (Iyer et al. 1996) are recruited to the damage site and repair
is initiated (Hanawalt & Spivak, 2008). The GG-NER in contrast detects and removes helix distorting lesions throughout the
whole genome. The exact mechanism of the damage recognition steps is still under debate. Aboussekhra et al. and Mu et al.
were able to reconstitute the repair mechanism in vitro allowing deciphering the core excision reaction of NER (Aboussekhra
et al. 1995; Mu et al. 1995). The NER assembly seems to be a sequential and coordinated process in which damage excision
and repair is mostly error-free. This repair process is characterized by five main steps (steps I–V): after damage recognition (I)
a multi-protein complex (‘preincision complex’ (PIC)) binds to the damage site (II) leading to a double asymmetric cut of the
damage-containing oligonucleotide strand. The damage-containing single-stranded DNA (ssDNA) fragment is eliminated
(III). Afterwards the double strand is reconstituted by filling the gap with the DNA polymerase (IV) and ligation of the
new synthesized strand takes place (V) (Shivji et al. 1995). In this work, we will only consider the GG-NER pathway.
1.4 DNA-structure/repair relationships
Because of its broad substrate specificity, it was speculated early on that the NER system does not recognize the lesion itself but
the distortion of the DNA structure. In 1997 Naegeli and co-workers discovered that for damage recognition a chemical modi-
fication of the nucleotide in addition to distortion in the DNA helix had to be present (Hess et al. 1996b). They could show that
neither a modified ribose moiety with intact Watson–Crick base pairing nor a DNA bubble of three base-pairs was recognized
and repaired by the NER system. However, placing the modified ribose moiety into a DNA bubble, created a well-recognized
NER substrate. These observations helped to formulate the ‘bipartite substrate discrimination’-model (Hess et al. 1996a, 1997a).
This model shows that only DNA damages that cause disrupted base pairing can be recognized as NER substrates. Furthermore,
a DNA helix distortion might be additionally needed for the correct recruitment of the NER machinery (Hess et al. 1996b). This
hypothesis explains why helix-distorting damages are more efficiently processed by NER (Gunz et al. 1996; Sugasawa et al. 2001).
These ideas can also explain why 6–4PPs are better substrates than CPD lesions. Not all adducts, induced by polyaromatic
hydrocarbons or aromatic amines, are good substrates for NER, because some adducts do not change the duplex structure,
e.g. N-(deoxyguanosin-8-yl)-2-aminofluorene. The aromatic ring of the lesion is easily accommodated in the minor or major
grooves of the DNA duplex. Lesions causing helix disruption upon intercalation of their aromatic ring inside the DNA helix
are typically good substrates for NER, e.g. N-(deoxyguanosin-8-yl)-2-acetylaminofluorene (dG-AAF), (Gillet et al. 2005; Mu
et al. 1994) or benzo[a]pyrene (Buterin et al. 2000; Geacintov et al. 2002; Hess et al. 1997a; Yan et al. 2003). Nowadays, it is
assumed that all parameters able to reduce the thermodynamic stability of the DNA play a role for the NER damage recognition
step. The repair rate is apparently proportional to the decrease of thermodynamic stability of the duplex induced by the discrete
DNA lesions (Aboussekhra et al. 1995; Geacintov et al. 2002; Gillet & Scharer, 2006; Gunz et al. 1996).
1.5 Damage recognition in NER
How does discrimination between undamaged and damaged DNA take place in the context of dominating undamaged DNA
present in the nucleus? The exact damage recognition process in NER is still unclear and as such it is the most challenging
current question associated with the NER process.
Several experiments with fluorescein-labeled proteins, such as ERCC1 (Houtsmuller et al. 1999), XPB (Hoogstraten et al.
2002) and XPA (Rademakers et al. 2003), in combination with photobleaching techniques showed that the repair proteins
move freely in the nucleus and accumulate successively at the damaged site. These observations argue that recognition factors
must initially bind to the damage site and subsequently recruit downstream factors. At the beginning of NER research XPA
was thought to be the initial damage recognizer in NER (Asahina et al. 1994; Jones & Wood, 1993). However, in 1998
Sugasawa et al. (Sugasawa et al. 1998) demonstrated in an in vitro experiment, that the complex XPC–RAD23B was the
first damage binder followed by participation of XPA. While for XPC–RAD23B the involvement in the GG-NER pathway
has been clearly shown, the complex is not necessary for TC-NER. XPA in contrast, is indispensable for both GG-NER
and TC-NER, which perhaps supports its central function in a later step of NER (Kobayashi et al. 1998; Sugasawa et al.
1998). The role of XPA requires further investigations.
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Biochemical experiments demonstrated that the UV-damaged DNA-binding protein (UV-DDB) (Fujiwara et al. 1999; Keeney
et al. 1993; Reardon et al. 1993), XPC–RAD23B (Batty et al. 2000a; Raoul et al. 1995; Sugasawa et al. 1998, 2001), XPA
(Buschta-Hedayat et al. 1999; Jones & Wood, 1993; Li et al. 1995a) and replication protein A (RPA) (Burns et al. 1996;
Mellon et al. 1987; Reardon & Sancar, 2002; Schweizer et al. 1999) show all affinity to damage-containing DNA. XPC–
RAD23B binds specifically to DNA lesions such as 6–4PP (Batty et al. 2000a; Kusumoto et al. 2001; Raoul et al. 1995), cisplatin
(Evans et al. 1997b;Hey et al. 2002;Moggs et al. 1996, 1997; Sugasawa et al. 1998), dG-AAF (Sugasawa et al. 1998) and cholesterol
adducts (Kusumoto et al. 2001; Sugasawa et al. 2001). It recognizes CPD damages (Kusumoto et al. 2001) poorly although their
repair is strongly dependent on the presence of XPC (Venema et al. 1991). The affinity ofXPC–RAD23B toCPDs can be enhanced
by mismatches surrounding the lesion (Sugasawa et al. 2001). XPA alone or in combination with RPA binds to DNA containing
bulky adducts such as dG-AAF (Liu et al. 2005; Yang et al. 2002). By far the strongest DNA binding for XPA are DNA junctions
which suggest that XPA interacts with an intermediate structure rather than directly with a lesion (Missura et al. 2001).
Photoaffinity-crosslinking experiments demonstrate that XPC–RAD23B (Maltseva et al. 2007), as well as XPA (Wakasugi &
Sancar, 1999) show a high affinity to damaged DNA without binding directly to the lesion (Reardon & Sancar, 2002).
Reconstitution experiments withNER-deficient cells with all the differentNERproteins in different order delivered contradictory
results. Sugasawa et al. showed a fast repair rate when the cells where preincubated with XPC–RAD23B (Sugasawa et al. 1998).
Preincubation of the damaged plasmids with XPA–RPA slowed down the repair velocity. Experiments fromWakasugi et al. how-
ever showed a more effective repair when damaged DNA was preincubated with XPA/RPA (Wakasugi & Sancar, 1999).
1.6 Overview of each XP protein and its role in GG-NER
In Fig. 2, the different steps of the GG-NER mechanism are depicted. It is believed that XPC–RAD23B initiates the GR-NER
by recognition of the damage (Fig. 2a, b) (Reardon & Sancar, 2003; Sugasawa et al. 1998; Wakasugi & Sancar, 1998). XPC
ignores the lesion but binds to the ssDNA opposite to the lesion (Min & Pavletich, 2007). In the case of UV lesions, the
Fig. 2. Overview of the global genome-NER mechanism (Friedberg, 2001; Li et al. 2015).
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recognition process by XPC–RAD23B is sustained by the UV-DNA damage-binding protein 2 (UV-DDB2) (Luijsterburg
et al. 2010; Min & Pavletich, 2007; Riedl et al. 2003; Volker et al. 2001). After this step, the general transcription factor
TFIIH is recruited to the lesion site using the energy provided by the ATPase activity of XPB (Fig. 2c). Normally, TFIIH
is involved in transcription by RNA polymerases I and II, but in the presence of DNA damage it is clearly recruited 5′ to
the damage site (Hoogstraten et al. 2002). Two subunits of TFIIH, the ATP-dependent DNA helicases XPB and XPD, are
needed for ‘hooking up’ TFIIH at the lesion site performing further unwinding and damage verification. It is believed
that XPB opens the DNA and facilitates the binding of XPD to the DNA which verifies the chemical modification of the lesion
(Scharer, 2013). In addition, XPD scans the strand with the lesion and both helicases are stalled when XPD encounters a bulky
lesion (Li et al. 2015; Mathieu et al. 2013). In the next step, XPA and RPA (Fig. 2d, e) are thought to be recruited to the
damaged site to form the PIC which is stabilized by the structure specific endonucleases XPG (Fig. 2e). Upon arrival of
XPG to the PIC, XPC–RAD23B leaves the complex (Riedl et al. 2003; Wakasugi & Sancar, 1998). Besides XPD, XPA might
be involved in damage verification, however, the details of this event remain elusive (Naegeli & Sugasawa, 2011; Tapias et al.
2004). The ssDNA-binding protein RPA now binds the undamaged strand, while TFIIH opens the duplex. XPA is then thought
to recruit the structure specific endonucleaseXPF–ERCC1heterodimer (Li et al. 1995a; Tsodikov et al. 2007) and incision on both
sites of the lesion takes place. The first incision 5′ of the lesion ismade by XPF–ERCC1 (Staresincic et al. 2009). Then, XPG cuts 3′
to the lesion (Fagbemi et al. 2011) triggering the elimination of a 24–32 oligonucleotide containing the lesion (Fig. 2f) (Edenberg
&Hanawalt, 1972; Evans et al. 1997b; Ikegami et al. 1998). After that, DNA replication by the polymerases κ/δ/ϵ takes place sus-
tained byother factors (PCNA,RFC andRPA) (Ogi et al. 2010). Finally, the new synthesizedDNAstrand ismostly sealed byDNA
ligase III/XRCC1. DNA ligase I is only recruited to sites of UV damage in proliferating cells (Fig. 2g) (Moser et al. 2001, 2007;
Reardon & Sancar, 2005; Wood, 1997). Table 1 gives an overview of the XP proteins, their function and size, their interaction
partners as well as the PDB codes of solved structures associated to the DNA substrates.
2. XPE (UV-DDB2)
For the recognition of UV lesions such as 6–4PPs and CPD, the UV-DDB protein seems to promote binding of XPC–
RAD23B to the damaged site (Scrima et al. 2008). The UV-DDB protein, consists of the two subunits DDB1 (also called
p127 with 127 kDa, 1149 amino acids) and DDB2 (called p48 with 48 kDa, 428 amino acids) (Fig. 3a). It shows a 100- to
1000-fold higher affinity to photolesions than XPC–RAD23B (Keeney et al. 1993; Takao et al. 1993). Both subunits are
required for the activity of the complex (Hwang et al. 1998a; Keeney et al. 1993; Nichols et al. 1996). UV-DDB is known to
be involved in the DNA damage recognition process of GG-NER (Wakasugi et al. 2002). The DDB2 subunit binds with
Table 1. Overview of the XP proteins involved in NER and TLS. ERCCX: Excision repair cross-complementing rodent repair deficiency comple-
mentation group X. Af: Archaeoglobus fulgidus, Dr: Danio rerio, Sa: Sulfolobus acidocaldarius, Ape: Aeropyrum pernix, Ta: Thermoplasma acid-
ophilum, AAF-dG: N-(2′-desoxyguanosin-8-yl)-2-acetylaminofluorene, 6–4PP: 6–4PP, CPD: cyclobutane–pyrimidine dimer. PDB codes depicted
in bold refer to NMR structures.
Protein (gene) Function Protein size (aa) Interaction partner PDB code DNA substrate












XPC–RAD23B (XPC) Damage recognition XPC: 106 kDa (940)








XPE (UV-DDB1/2) Damage recognition
of UV lesions
DDB1: 127 kDa (1149)
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5′-endonuclease 104 kDa (916)
33 kDa (297)




XPG (ERCC5) 3′-endonuclease 133 kDa (1186) XPA, TFIIH, PCNA, XPD 4Q0W (Rad2) dsDNA with ss overhang
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preference to 6–4PPs but it also recognizes CPD lesions and it also binds abasic sites as well as DNA bubbles (Fujiwara et al.
1999). DDB1 is not involved in DNA binding. Mutation of the DDB2 subunit leads to a loss of function of the UV-DDB protein
found in XP complementation group E (XPE) in patients (Chu & Chang, 1988). XPE-deficient cells are shown to be defective in
GG-NER (Hwang et al. 1999). Wakasugi et al. showed that UV-DDB rapidly accumulates in vivo independently of XPA and
XPC at DNA damage sites after UV-irradiation (Wakasugi et al. 2002). Furthermore, they showed that UV lesions are mostly
recognized by UV-DDB which then recruits XPA and XPC.
2.1 Crystal structure of human XPE with 6–4PP damaged dsDNA
Scrima et al. (2008) solved the crystal structure of the UV-DDB (human DDB1, HsDDB1 and the zebrafish DDB2 ortholog,
DrDDB2) protein in complex with double-stranded DNA (dsDNA) containing the 6–4PP photolesion (Fig. 3b). In order to
achieve damage recognition the UV-DDB2 protein inserts a β-hairpin into the minor groove of the DNA. In addition, the
damaged dinucleotide is flipped out of the double helix and inserted into a binding pocket of the protein leading to a
DNA kink of about 40° at the lesion site. This destabilized conformation of the DNA might trigger the subsequent recruit-
ment of XPC–RAD23B and further downstream factors. Due to the importance of DDB2, defective cells show a remarkable
reduced CPD repair activity that gives rise to the XP-E phenotype (Hwang et al. 1998a; Tang et al. 2000).
2.2 Crystal structure of human XPE with CPD damaged dsDNA
Fischer et al. (2011) obtained insight into the molecular basis of CPD lesion recognition by solving the crystal structure of the
UV-DDB protein in complex with CPD containing DNA. For obtaining the structure, residues creating crystal contacts in the apo-
protein that prevented protein crystallization were mutated. Consistent with the structure of Scrima et al. (2008) the CPD lesion is
held by the DDB2 WD40 propeller. The crystal structure shows that the lesion recognition takes place with the help of a β-hairpin
(‘finger’) consisting of the residues Phe371, Gln372 and His373 (Fig. 3c). This β-hairpin inserts into the minor groove of the DNA
duplex at the damage site and unwinds the duplex by 12.6°. Consequently the CPD lesion is extruded into an extrahelical, flipped-
out state. Finally, the DNA shows also a kink angle of about 45° at the cis–syn CPD lesion site.
The UV-DDB protein is part of an ubiquitin ligase complex. The displacement of COP9 signalosome (CSN) from this com-
plex by DDB2 substrate binding leads to ubiquitination of XPC and DDB2 (Groisman et al. 2003; Luijsterburg et al. 2007).
This is thought to mediate the handover to XPC by stabilizing it, resulting in an increase of its affinity for damaged DNA,
while the affinity of DDB2 to DNA containing a lesion is reduced (El-Mahdy et al. 2006; Sugasawa et al. 2005). Histones
surrounding the lesion are ubiquitinated as well, which is suggested to slacken the nucleosome structure to promote recruit-
ment of NER repair enzymes to the damage (Wang et al. 2006).
2.3 Crystal structure of human XPE with an abasic lesion site in dsDNA
Yeh et al. (2012) solved a dimeric crystal structure of UV-DDB (human DDB1 and DDB2) protein in complex dsDNA con-
taining an abasic site (THF) (Fig. 3d). Each DDB2 subunit is bound to one double-stranded oligonucleotide. The DDB2 residues
Asn360/Asn360 are located between the two DNA strands spanning two antiparallel β-strands (β-wing) and giving rise to a
2-fold symmetry axis of the dimer. The crystal structure shows that the residues on the leading β-strand and loop form contacts
with the undamaged DNA strand and the residues on the loop and the retreating β-strand form contacts with the neighboring
undamaged DNA strand. These contacts are supported by additional interactions of the N-terminal-helical domain of DDB2
(α-paddle) with the neighboring DNA-strand which lead to dimerization, explaining the high affinity to damaged DNA.
3. XPC
The human XPC protein is a polypeptide of 940 amino acids with a size of 106 kDa, forming a stable complex with the
RAD23B protein (43 kDa, 409 amino acids). It is currently believed that XPC–RAD23B is responsible for the initial damage
recognition with the exception of CPD lesions, where DDB2 is the first binding factor (Hey et al. 2002; Sugasawa et al. 2001).
The complex is known to interact with several other proteins, e.g. XPA and TFIIH (Fig. 4a, b) (Araujo et al. 2001;
Bernardes de Jesus et al. 2008; Cleaver et al. 2009). After binding, the protein recruits further downstream factors to the
damaged site (Sugasawa et al. 1998). Biochemical assays show that the XPC–RAD23B complex binds with high affinity to
different DNA lesions, e.g. 6–4PP and AAF-adducts (Batty & Wood, 2000b; Sugasawa et al. 2002). The breakthrough
came in 2001 when the Mullenders group was able to show that XPC might be the initial damage recognizer also for UV
lesions. In the experiment, nuclei of living cells were irradiated with UV light at defined positions through a porous polycar-
bonate filter (Katsumi et al. 2001; Mone et al. 2001; Volker et al. 2001). The generated UV lesions could be detected by anti-
bodies specific against CPDs and 6–4PPs. To identify which NER factors were recruited to these sites they were also visualized
7
https://doi.org/10.1017/S0033583515000268
Downloaded from https://www.cambridge.org/core. UB der LMU München, on 03 Dec 2018 at 14:01:54, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.
Fig. 3. Crystal structures of the human XPE protein (UV-DDB). (a) Schematic representation of the human UV-DDB protein (DDB1
and DDB2) with the different domains. (b) Crystal structure of the XPE protein in complex with 6–4PP damaged DNA (PDB code:
3EI1) (Scrima et al. 2008). DDB1 is depicted in green, DDB2 in blue, DNA in gray and the 6–4PP dinucleotide in red. (c) Crystal struc-
ture of XPE in complex with the CPD lesion (PDB code: 4A08) (Fischer et al. 2011). DDB1 is depicted in green, DDB2 in blue, DNA in
gray and the CPD lesion in orange. (d) Crystal structure of the dimeric human UV-DDB in a complex with an abasic lesion (PDB code:
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with an appropriate antibody. This experiment revealed that XPC colocalized with UV lesion sites in XPA-deficient cells,
while XPA was not recruited in XPC-deficient cells (Volker et al. 2001). Thus, it was concluded that XPA needs the presence
of XPC to be recruited to the damaged site and that XPC is the first factor being recruited to the damaged site. Further inves-
tigations pointed out that XPC is also required to unwind the DNA at the damaged site in order to recruit NER downstream
factors (Katsumi et al. 2001; Mone et al. 2001). It has to be addressed that these experiments refer to the recognition of UV
lesions. The general lesion recognition strategy adopted by XPC was established by a variety of experiments with different
DNA lesions (Tapias et al. 2004). The helicase activity of XPD is not required for transcription but is indispensable for
the NER process. The combined data show that XPC might be more structure specific than lesion specific. The XPC–
RAD23B complex is able to recognize ssDNA (Maillard et al. 2007) and DNA containing destabilizing lesions.
Additionally it was shown, that the complex binds the DNA lesion in an asymmetric fashion (Sugasawa et al. 2002;
Wakasugi & Sancar, 1999). Interestingly, the complex also binds to 3−5 unpaired bases independently of the presence of dam-
age. However, repair takes place only in the presence of DNA damage (Hess et al. 1997b; Sugasawa et al. 2001).
Hence, XPC might be a sensor for unpaired base pairs that occur in bubbles and loops and binds those in complex with
RAD23B (Araki et al. 2001; Van der Spek et al. 1996) and Centrin2 (Araki et al. 2001). This would explain why 6–4PP,
AAF-dG and intrastrand cisplatin crosslinks, which introduce a severe helical kink into the DNA structure (Lukin & de
Los Santos, 2006), are good substrates. On the other hand, CPDs are not recognized, possibly because they do not disturb
the helical structure (Kusumoto et al. 2001; Reardon & Sancar, 2003; Sugasawa et al. 2001). As mentioned previously the af-
finity of XPC–RAD23B to CPDs can be enhanced by introducing mismatches at the lesion site (Sugasawa et al. 2001).
3.1 Crystal structure of yeast XPC (Rad4) in complex with a CPD lesion
Min & Pavletich, (2007) obtained the crystal structure of the yeast homolog of XPC–RAD23B (Rad4-Rad23, Fig. 5a) in com-
plex with a CPD lesion in a mismatched situation with two thymidines (Fig. 5b). A shorter version of the protein (the
DNA-binding domain) showing the same affinity to damaged DNA as the full length protein was crystallized. The crystal
structure shows that Rad4 inserts a β-hairpin (beta hairpin domain 3, (BHD3)) into the destabilized DNA duplex, inducing
the two damaged base pairs to completely flip out of the double helix (base flipping). A kink of 42° is created which could be
confirmed by atomic force microscopy (Hwang et al. 1999). The protein recognizes the expelled nucleotides of the undamaged
strand through Van der Waals interactions with BHD1 and transglutaminase homology domain (TGD), while the two
CPD-linked nucleotides are disordered in the structure and could not be resolved. The protein undergoes a conformational
change during binding to damaged DNA (induced fit). The authors deduced from these findings that the lesions recognized by
XPC must thermodynamically destabilize the Watson–Crick double helix in a manner that facilitates the flipping-out of two
bases. The protein recognizes a weakened and distorted DNA helix without binding directly to the damage.
The structure, however, does not explain why the CPD damage alone, without a mismatch, is so efficiently repaired by NER.
For UV lesion repair, additional damage recognition factors must exist. New experiments show that the UV-DDB protein
plays a very important role and that this protein recruits the XPC–RAD23B protein to the UV-damaged sites (Fitch et al.
2003; Wakasugi et al. 2002). Also the 6–4PP lesion which is a better NER substrate than CPD (Mitchell & Nairn, 1989),
requires XPC–RAD23B as well as UV-DDB for recognition. See Section 2.
Camenisch et al. (2009) proposed a two-stage detection process for XPC that recognizes DNA lesions without involvement of
a DNA-binding domain (BHD3). BHD1/BHD2 and a β-turn subdomain act as a damage sensor that scans the double helix
Fig. 4. Schematic representation of human XPC and RAD23B. (a) The TGD domain of XPC is depicted in green, the BHD1 domain in
light blue, the BHD2 domain in blue and the BHD3 domain in dark blue. (b) The UBA1 and UBA2 domains of RAD23B are depicted in
light orange and orange, respectively.
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for unpaired bases, which forms a labile recognition complex. Subsequently, a stable recognition is formed through binding of
BHD3 to the flipped out nucleotides in the undamaged strand across the lesion (Camenisch et al. 2009).
Chen et al. (2015) obtained the crystal structure of the yeast homolog of XPC–RAD23B (Rad4–Rad23) in complex with unda-
maged DNA using disulfide crosslinking. The crystal structure shows that Rad4 flips out normal nucleotide pairs like with
damaged DNA. Therefore, structural discrimination of Rad4/XPC cannot play an important role for lesion recognition.
The authors propose a ‘kinetic-gating’ mechanism for Rad4/XPC lesion recognition, which is controlled by two kinetic para-
meters (opening time and residence time). The weakened base stacking and hydrogen bonding within a lesion lead to a larger
Fig. 5. (a) Schematic representation of Rad4 and Rad23. The TGD domain is depicted in pink, BHD1 in dark blue, BHD2 in cyan,
BHD3 in blue and R4BD in green. (b) Crystal structure of the yeast Rad4–Rad23 in complex with a CPD damaged DNA (PDB code:
2QSG) (Min & Pavletich, 2007). Same color code as in (a). The extruded Ts in front of the CPD lesion are depicted in orange.
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opening time for damaged DNA than for undamaged DNA to form a stable recognition complex. Also, the residence time is
larger for damaged DNA indicating that Rad4/XPC opens damaged DNA with a higher probability (Chen et al. 2015).
4. XPB
XPB (also called ERCC3) is a 3′–5′ ATP-dependent DNA helicase and a subunit of the TFIIH complex necessary for tran-
scription and DNA repair (Gillet & Scharer, 2006; Lehmann, 2003; Schaeffer et al. 1993). Mutations in XPB lead to a
1000-fold increase of the melanoma risk and neurological abnormalities because of a defective TFIIH function in NER
(Lehmann, 2003). The human protein consists of 782 amino acids (89 kDa). NER helicases (XPB and XPD) all include con-
served Rad51/RecA like ATPase domains called helicase domains 1 and 2 (HD1 and HD2), containing the ATPase and heli-
case motifs characteristic for superfamily 2 (SF2) helicases (Shin et al. 2003; Story & Steitz, 1992). Furthermore, NER helicases
consist of two accessory domains, which are responsible for transmitting the helicase domain changes upon binding to DNA.
The ATPase activity of XPB is necessary during NER to anchor TFIIH to the lesion site (Abdulrahman et al. 2013; Coin et al.
1998; Dubaele et al. 2003; Oksenych et al. 2009). Its helicase activity is, however, not needed for the repair process (Coin et al.
2007; Oksenych et al. 2009; Tirode et al. 1999).
4.1 Crystal structure of Archaeglobus fulgidus XPB (AfXPB)
Fan et al. (2006) determined the crystal structure of an A. fulgidus XPB homolog (AfXPB) with a sequence equivalent to resi-
dues 240–686 of the human XPB (Fig. 6b). The AfXPB structure is built up by two Rad51/RecA-like helicase domains, HD1
and HD2, containing seven conserved helicase motifs (Walker motif I, Ia and II–VI) in the middle of the polypeptide (Fig. 6a)
Fig. 6. (a) Schematic alignment of XPB and AfXPB showing the different domains: The DRD domain is depicted in blue, HD1 in light
blue, HD1 in yellow, ThM in green and CTE (C-terminal extension) in pink. The conserved helicase motifs (Walker A motif I–VI) are
depicted in orange. (b) Crystal structure of the AfXPB protein (PDB code: 2FWR). (Fan et al. 2006). Same color code as in (a). (c)
Crystal structure of C-terminal domain of the human XPB protein (PDB code: 4ERN) (Hilario et al. 2013). Same color code as in (a).
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(Fuss & Tainer, 2011; Tuteja & Tuteja, 1996). These domains use the binding and hydrolysis of ATP to induce conformational
changes of the protein. Furthermore, the protein contains a DNA damage recognition domain (DRD), a unique RED motif
(Arg–Glu–Asp) and a thumb domain (ThM). These domains are highly conserved and they are also found in the correspond-
ing human protein. The structure suggests that the ATP hydrolysis provides the energy to induce a flip of about 170° in the
orientation of HD2 relative to HD1 after DNA binding (Fig. 7). This conformational change brings the RED domain and the
ThM domain in close vicinity and stabilizes TFIIH on the DNA by inserting a wedge (Glu473) into the double strand, gripped
by the ThM domain. The motion might be important for melting the DNA duplex and anchoring TFIIH (Coin et al. 2007).
Mutations in the RED and ThM domains as well as mutations in the ATPase domain diminish the helicase activity, suggesting
that these three domains ensure the correct recruitment of TFIIH to the damaged site.
4.2 Crystal structure of human XPB
Hilario et al. (2013) successfully solved the crystal structure of the C-terminal fragment of human XPB (residues 494–782)
containing the helicase domain 2 (HD2), the thumb-like domain (ThM) and the C-terminal extension (Fig. 6c). They inves-
tigated the structural basis for the role of the C-terminus of XPB in transcription and DNA repair. Because of lack of electron
density in the structure, only the positions of the residues 502–730 could be determined. The observed structure consists of a
globular domain containing a central sheet of seven parallel β-strands sandwiched by three α-helices on one side and two
α-helices on the other (Fig. 6c). The C-terminal extension (residues 670–730) is built up by two α-helices linked by a loop
and a β-strand, which forms the edge strand of the seven-stranded central sheet, and an unstructured tail that possibly extends
to the C-terminus. The ThM domain and one α-helix of the C-terminal extension are located at the top of the central sheet.
Thus, the recruitment of TFIIH to the damage site is an active process controlled by the ATPase motif of XPB. This suggests
that this subunit acts as an ATP-dependent hook that stabilizes the binding of the TFIIH to damaged DNA (Hilario et al.
2013). In fact, a mutated ATPase activity of XPB abolishes the NER activity (Guzder et al. 1994; Sung et al. 1988).
Recruiting TFIIH to the damage site by the ATPase activity of XPB may reorganize the protein–DNA complexes in order
to allow new protein–protein or protein–DNA contacts to happen.
5. XPD
The XPD (also called ERCC2) protein with a size of 87 kDa (760 amino acids) is known to be involved in transcription and
DNA damage repair. It is a key subunit of the TFIIH complex and acts as an ATP-dependent 5′–3′ DNA helicase that belongs
to the superhelicase 2 family (SF2) proteins (Araujo et al. 2000; Coin et al. 2007). The helicase activity of XPD is not required
for transcription but is indispensable for the NER process (Winkler et al. 2000). The TFIIH complex interacts with other NER
factors such as XPA, XPC, XPG and XPF–ERCC1 (Evans et al. 1997a; Gillet et al. 2005). Mutations in human XPD lead to
three different inherited diseases: XP, the CS and TTD. XPD is thought to be responsible for the damage verification (Mathieu
et al. 2010; Naegeli et al. 1993) before the recruitment of downstream NER factors to the lesion site occurs. This idea has been
postulated based on the observation that the helicase activity of XPD becomes inhibited by the presence of DNA damage
(Mathieu et al. 2010, 2013; Naegeli et al. 1992).
Fig. 7. Proposed model for binding of XPB to DNA (adapted from Fan et al. (2006)). The apo-protein is in an opened conformation.
By binding to DNA, a rotation (170°) of the second helicase domain (HD2) together with the ThM domain, facilitated by HD1-mediated
ATP hydrolysis, takes place and forms the closed and stable XPB–DNA complex. Same color code as in Fig. 6a.
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5.1 Crystal structure of Sulfolobus acidocaldarius XPD (SaXPD)
Several crystal structures of the catalytic domain of XPD from different organisms (S. acidocaldarius (Fan et al. 2008) (SaXPD;
Fig. 8), Thermoplasma acidophilum (Wolski et al. 2008) (TaXPD) and Sulfolobus tokodaii (Liu et al. 2008)) reveal a four do-
main organization: a domain harboring the 4Fe4S iron–sulfur cluster (FeS domain), an arch domain and two canonical
Rad51/RecA like domains, the helicase domains HD1 and HD2 (Fig. 8a). The FeS domain is essential for the helicase activity
of XPD.
The different domains form a tunnel that is large enough to harbor ssDNA (Fig. 8b, c) (Fan et al. 2008; Liu et al. 2008; Wolski
et al. 2008). Fan et al. proposed a model of XPD binding to ssDNA (Fig. 9) (Fan et al. 2008). The iron–sulfur cluster is sup-
posed to act as a molecular plough, which scans blocking damages by breaking hydrogen bonds (Lehmann, 2008; White,
2009). In this process, one strand of the duplex is supposed to be pulled through the internal channel with the help of the
ATP-dependent motor domain, while damaged DNA will plug the channel (Fan et al. 2008; Liu et al. 2008; Mathieu et al.
2013; Pugh et al. 2012; Wolski et al. 2008). In this way, the protein undergoes a conformational change by closing the domain
between the arch and the FeS motifs. The helicase domains HD1 and HD2 furnish the necessary flexibility for translocation
(Fan et al. 2008).
Because the channel is not narrow enough to distinguish between damaged and undamaged bases 2008, Wolski et al. pro-
posed that during the unwinding process single bases are analyzed through insertion of the DNA backbone into a neighboring
binding pocket on the protein surface. Damaged bases would not fit into the pocket, which could be the signal that leads to
blocking of the helicase activity (Wolski et al. 2008).
5.2 Crystal structure of T. acidophilum (TaXPD) in complex with ssDNA
Finally, in 2012 Kuper et al. successfully solved the crystal structure of TaXPD in complex with a ssDNA oligonucleotide
(22mer), shedding light on the mechanism of polarity and translocation of the protein along the DNA (Kuper et al.
2012). At the same time Pugh et al. showed that the 5′–3′ translocation polarity needs conserved residues in the HD1 and
the FeS domains. They propose that the FeS domain provides a wedge-like feature enabling the duplex opening during
unwinding (Pugh et al. 2012).
Fig. 8. (a) Schematic representation of human XPD (Fan et al. 2008). The protein interacts with XPGC (C-terminal domain of XPG)
and XPGN (N-terminal domain of XPG) depicted in brown. (b) Crystal structure of SaXPD (PDB code: 3CRV) (Fan et al. 2008) with the
HD1 domain (light blue) and the HD2 domain (green) form the ATP-binding interface. The arch domain is depicted in blue and FeS do-
main in red. The iron–sulfur cluster (4Fe4S) is depicted in orange and yellow. (c) Surface representation of SaXPD showing the tunnel
formed by the different domains, which is large enough to pass through ssDNA.
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The structure allowed the Kisker group to define the translocation path of the DNA substrate through the protein and to
determine the DNA-binding domain (DBD) of TaXPD by mutational and biochemical analysis. Only four bases (TACG)
of the oligonucleotide could be identified in the electron density. These bases are located in the cleft of the HD2 domain
(Fig. 10). This domain was already predicted as a potential binding cleft by Wolski et al. (2008). The structure shows stacking
of Trp549 with the adenine of TACG. Arg584 builds hydrogen bonds with N1 and N2 of the phosphate backbone of adenine
and cytosine. Phe538 does not directly contact the DNA, but it is supposed to stabilize larger bases like adenine or guanine. A
fourth residue Asp582 stabilizes Arg584 by hydrogen bonding to maintain it in position for DNA binding. The 5′ end points
away from the HD2 domain and the 3′ end points towards HD1 domain. Kuper et al. propose a model (Fig. 10) which shows
how the ssDNA is situated and translocated in the protein.
5.3 Proposed model of damage verification
Based on these new data about XPD, Fuss and Tainer proposed an extended model of the damage verification process, the
so-called ‘bind-pry-unwind’-model: (Fuss & Tainer, 2011) here XPB, XPD and CAK of the TFIIH complex are all considered
to be essential for the coordination of damage recognition, verification, repair and signaling. In this model, the damage rec-
ognition proteins not only recruit the TFIIH complex and other NER factors to the damage site, but also fix the DNA at the
same time. Kim et al. suggested that XPB facilitates the unwinding of the DNA duplex during transcription by distorting the
Fig. 9. DNA-binding model of SaXPD adapted from Fan et al. (2008). The HD1 domain is depicted in light blue, the HD2 domain in
green, the arch domain is depicted in blue, the FeS domain in red and the DNA in gray. Upon binding to the DNA the protein under-
goes a conformational change by closing the domain between the arch and the FeS domains.
Fig. 10. Crystal structure of Thermoplasma acidophilum XPD (TaXPD) in complex with a 10 nt ssDNA. The arch domain is depicted in
dark blue, the FeS domain in red, the HD1 domain in cyan and the HD2 domain in green. The four bases (TACG), showing electron
density, are depicted as gray sticks. The modeled ssDNA in the pore is schematically represented in gray. The modeled structure is
adapted from Kuper et al. (2012).
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DNA underneath the transcription bubble, which is fixed by the transcription factors and RNAP II (Kim et al. 2000).
Similarly XPB could unwind and open the DNA. In that way, the damage verification step and the DNA unwinding
could be linked. These findings are in accord with the low helicase activity of XPB and its strong conformational change
upon binding to DNA (Fan et al. 2006). Furthermore, TFIIH can thereby position itself directly next to XPC–RAD23B or
RNAP II, which establishes a common mechanism of how XPB may act in GG-NER, TC-NER and transcription.
Through its short binding canal, XPB could place TFIIH vertically to the DNA and 5′ of the recognition protein. Then
XPB could break the DNA strand, so that TFIIH bends it towards the DNA enabling XPD to bind about 22 base pairs
away from the lesion on the damaged strand. Fuss and Tainer assume that the distance between XPB and XPD determines
the size of the open DNA-bubble, corresponding to about 27 base pairs that are eliminated during NER. XPA catalyzes the
release of CAK from the TFIIH complex (Coin et al. 2008). This step signals that the repair process can be continued and
promotes the incision step. The XPD helicase unwinds the duplex until the 4Fe4S-cluster docks onto the damage and is
blocked by it (Mathieu et al. 2010; Naegeli et al. 1993). Recent studies show that XPD exists in different conformations
depending on the type of damage (Buechner et al. 2014). After the blockage, XPD and XPC–RAD23B anchor the TFIIH com-
plex and build a platform for binding of ERCC1-XPF and XPG (Araujo et al. 2001).
Following this model RPA, XPA and XPG probably reach the lesion site independently and build together with TFIIH the
pre-incision complex (Rademakers et al. 2003; Riedl et al. 2003; Volker et al. 2001; Wakasugi & Sancar, 1998). Here, all
NER factors, except ERCC1-XPF, are present and stably bound to the open DNA bubble.
Recently, the Kisker group showed by mutational analysis that the FeS domain of XPD is crucial for NER (Kuper et al. 2014).
Furthermore, the successful repair process is dependent on the enzymatic activities of XPD which involves DNA binding,
ATPase activity, helicase activity and the correct interaction with other TFIIH subunits. In 2013, the Naively group showed
by uncoupling the DNA unwinding activity from the damage verification activity of XPD, that residues Tyr192 and Arg196
form a sensor pocket located ahead of the narrow central protein pore responsible for damage recognition. By mutating these
two residues, the helicase and ATPase activities are not affected but the damage sensing during ATP-driven scanning
movement along nucleic acid lattices fails and the ability of XPD to form stable DNA damage recognition intermediates is
significantly reduced (Mathieu et al. 2013). The activity of XPD however is not relevant for transcription and DNA binding.
6. XPA
The XPA protein (xeroderma pigmentosum group complementation group A) consists of 273 amino acids (31 kDa) and can
occur as either a homodimer or in complex with other NER proteins (Liu et al. 2005; Yang et al. 2002). The protein is con-
stituted of several domains (Camenisch et al. 2006; Camenisch & Nägeli, 2008): the N-terminal domain (XPA4–97) includes
the RPA34- and ERCC1-binding regions (He et al. 1995; Li et al. 1995a). The C-terminal domain (XPA226–273) interacts with
TFIIH (Camenisch & Nägeli, 2008; Ikegami et al. 1998; Park et al. 1995a). The central domain (XPA98–219) is the minimal
DBD (XPA-DBD) (Cleaver & States, 1997; Kuraoka et al. 1996). The protein contains a zinc-finger binding domain
(Cys105-X2-Cys108-X17-Cys126-X2-Cys129) (Hess et al. 1998). The C4–zinc finger sustains the stability of the protein and
plays a role in the interaction with RPA70 (Fig. 11a) (Ikegami et al. 1998; Kuraoka et al. 1996; Morikawa & Shirakawa,
2000; Morita et al. 1996; Sugitani et al. 2014). Mutation of one or all zinc-binding cysteines leads to a loss of function of
XPA and to an almost complete loss of function of NER (Li et al. 1995b; Mellon et al. 1987).
It has been demonstrated that XPA binds ssDNA, dsDNA and denaturated stretches of DNA in cooperation with RPA
(Buschta-Hedayat et al. 1999; Missura et al. 2001; Wang et al. 2000; Yang et al. 2006). XPA shows binding affinity to irradiated
DNA (Jones & Wood, 1993; Liu et al. 2005), DNA containing bulky adducts and cisplatin lesions (Jones & Wood, 1993; Liu
et al. 2005), as well as toDNAduplexes containing loops and bulges (Camenisch et al. 2006). Camenisch et al. could show bymuta-
tional analyses that the residues Lys141 and Lys179 foundon the surface ofXPAnext to theDNA-binding pocket are responsible for
the sensing of DNA deformability as the common characteristics of damaged sites (Camenisch et al. 2006;Miyamoto et al. 1992). It
was postulated that these two lysines interact with the DNA backbone, when XPA is in complex with RPA and kinked DNA (Read
et al. 1993;Weir et al. 1993). Photocrosslinking experiments demonstrated that themutated protein does interact with kinkedDNA
structures (Camenisch et al. 2006). This led to the assumption that the protein scans the DNA duplex for the presence of the kinked
DNAstructurewith its positively charged pocket. The loop-rich domain ofXPAwasdetermined to be responsible forDNAbinding.
The ternary structure is stabilized by the zinc-finger domain (Miyamoto et al. 1992; Yan et al. 2002).
6.1 Nuclear magnetic resonance (NMR) structure of the DBD of human XPA
Ikegami et al. (1998) determined the NMR structure of the DBD of XPA (XPA98–219, called XPA-DBD) and they found that
the protein contains α-helices and β-sheets (Fig. 11b). The structure shows the presence of a positively charged (basic amino
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acids) cleft with the right dimension to bind dsDNA (Buchko et al. 1998, 2001). This positively charged cleft was speculated to
interact with the negatively charged DNA backbone.
Sugitani et al. (2014) redefined the DBD of XPA. By extending the originally characterized XPD-DBD at its C-terminus by 20
amino acids (XPA98–239), they improved the DNA-binding properties. The new construct with the additional critical basic
residues and helical elements at its C-terminus was found to bind to DNA substrates with the same affinity as the full-length
protein. The group reported, based on NMR data, that XPA98–239 contains the same globular core as XPA98−219 and similarly
undergoes a conformational change when binding to Y-shaped ss/ds-DNA junctions.
The rather small XPA protein interacts with a large number of other NER factors which supports its function as a scaffold
protein for the assembly of the incision complex during repair (Gillet & Scharer, 2006; Naegeli & Sugasawa, 2011). Probably,
XPA binds best to already prekinked DNA structures, which explains why XPA is able to bind defect Watson–Crick base
pairing, created by mismatches, bubbles or three-way junctions (Bootsma & Hoeijmakers, 1993; Buschta-Hedayat et al.
1999; Missura et al. 2001). These structures can form easily kinked DNA structures. XPA shows a slight binding preference
to UV-damaged DNA and bulky adducts over undamaged DNA (Jones & Wood, 1993; Robins et al. 1991; Thoma & Vasquez,
2003). Similarly to XPC, XPA recognizes 6–4PP lesions but not CPDs (Jones & Wood, 1993). CPD might block the bending of
major grooves because of its stiff four-membered ring which points into the major groove. XPA shows a high affinity to DNA
containing aromatic adducts and cisplatin crosslinks. Cisplatin crosslinks also kink the DNA structure. The damage recog-
nition capability of XPA increases with RPA (Jones & Wood, 1993; Li et al. 1995a; Mellon et al. 1987) and ERCC1
(Nocentini et al. 1997; Saijo et al. 1996). XPA does not bind ssDNA, in agreement with the observed size of the positively
charged cleft able to fit dsDNA (Buchko et al. 1998; Ikegami et al. 1998). For single-base bulky adduct lesions such as
AAF-dG, it is unclear to which extent they prekink the duplex. Bulky adducts can increase the local conformational flexibility
of DNA (Isaacs & Spielmann, 2004). XPA might employ a DNA flexibility scanning mechanism to create a kink, which could
be stabilized by intercalation of the aromatic ring into the duplex and may be the secret behind the broad substrate
Fig. 11. (a) Schematic view of the human XPA protein with XPA–DBD (DNA-binding domain, XPA98-219) in cyan the zinc-finger do-
main in gray. The binding domains of XPA with other NER proteins are depicted in light blue for RPA34, green for ERCC1, dark blue
for RPA70 and pink for TFIIH. (b) NMR-structure of the XPA–DBD (Buchko et al. 2001; Camenisch et al. 2006; Ikegami et al. 1998)
(PDB code: 1XPA). Positively charged amino acids that build the cleft are depicted as green sticks. The zinc atom is shown in gray.
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promiscuity of NER. Koch et al. could obtain two crystal structures of Rad14 with a bulky lesion, which confirm this hypoth-
esis (Koch et al. 2015).
6.2 Crystal structures of Rad14 with AAF-dG and cisplatin containing dsDNA
Recently, Koch et al. (2015) solved two crystal structures of the yeast homolog of XPA (Rad14) in complex with AAF-dG and
1,2-GG cisplatin containing DNA (Fig. 12b, c). The DBD of the protein (residues 188–306) was crystallized with damaged
DNA (Fig. 12a). The structures allow us to uncover the molecular mechanism of XPA interacting with damaged DNA
and are consistent with previous biochemical data showing the binding of XPA to kinked DNA structures
(Buschta-Hedayat et al. 1999; Camenisch et al. 2006). The protein assumes an overall α/β-fold quite similar to its human
homolog (Ikegami et al. 1998; Koch et al. 2015). Comparable with Rad4, Rad14 does not bind the lesion directly; instead
it recognizes a weakened DNA duplex structure (Min & Pavletich, 2007). By the binding of two Rad14 proteins to the duplex,
the DNA undergoes a sharp kink of 70° at the lesion site and single stranded regions are formed above and below the 13mer
binding motif. Through insertion of a β-hairpin (His258 and Phe262) from each protein (acting like ‘fingers’) exactly six base
pairs away from the lesion, a 13mer recognition motif is generated. Another domain composed of helix α7 (‘thumb’ contain-
ing Arg234 and Arg239) interacts with the DNA backbone close to the lesion, so that DNA bending takes place into the major
groove. The lesion is located inside the 13mer duplex instead of being flipped out. Because of the relatively few interactions
between Rad14 and the duplex, the protein might preferably bind already pre-kinked DNA structures (Camenisch et al. 2006).
The 2:1 complex can coordinate contacts between TFIIH, DNA and RPA and recruit ERCC1–XPF (Li et al. 1995a; Park et al.
1995b; Tripsianes et al. 2007).
7. XPF–ERCC1
The human DNA repair endonuclease XPF (gene called ERCC4) is a protein of 916 amino acids (104 kDa) (Brookman et al.
1996). It forms a stable ERCC1–XPF heterodimer enzyme complex that participates in DNA repair and DNA recombination
(Sijbers et al. 1996; Tsodikov et al. 2005). ERCC1 is a protein of 297 amino acids (32.5 kDa) that mediates DNA–protein and
protein–protein interactions. The XPF–ERCC1 complex cuts specific structures near an ss/dsDNA junction at the 5′-end of
single stranded damaged DNA strand and hence makes the first incision in the NER process. Its nuclease activity is absolutely
essential in the NER process (de Laat et al. 1999; Sijbers et al. 1996). In the complex, XPF provides the endonuclease active site
and is involved in DNA binding and establishing additional protein–protein interactions. XPF–ERCC1 is known to be the last
Fig. 12. (a) Schematic sequence of Rad14 with the DBD depicted in green, the zinc-finger domain in gray and the residues interacting
with the DNA in orange and pink. (b) Crystal structure of Rad14 in complex with AAF-dG crosslinked DNA (PDB code: 5A3D)
(Koch et al. 2015). Same color code as in (a). The AAF-dG residue is depicted in dark blue. (c) Crystal structure of Rad14 in complex
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factor joining the NER complex before dual incision takes place (Riedl et al. 2003; Volker et al. 2001; Wakasugi & Sancar,
1998). Evidence exists that it is recruited by XPA (Fig. 13a) (Li et al. 1994, 1995a; Park & Sancar, 1994; Saijo et al. 1996).
7.1 Crystal structure of human XPF–ERCC1
Tsodikov et al. (2005) solved the crystal structure of the minimal dimerization domains of the human XPF and ERCC1
(Fig. 13b). The crystallized domain shows a similar endonuclease activity compared to that of the full-length complex.
Both protein domains exhibit double helix–hairpin–helix motifs (HhH2) related by a pseudo-2-fold symmetry axis
(Tripsianes et al. 2005). The HhH2 motifs are known to be ds- as well as ss-DNA-binding motifs (Newman et al. 2005;
Singh et al. 2002). Both C-terminal HhH2 domains of XPF and ERCC1 are essential and sufficient for a stable heterodimer
formation (de Laat et al. 1998). XPF might play a role as a scaffold protein, allowing proper folding of the ERCC1 domain. All
XPF family members contain a catalytic domain comprising the active site motive (GDXnERKX3D) and they need a divalent
cation for their nuclease activity (Nishino et al. 2003; Sijbers et al. 1996).
7.2 NMR structure of C-terminal human XPF in complex with ssDNA
Das et al. (2012) solved the NMR structure of the C-terminal domain of the human XPF protein (residues 823–905) in com-
plex with a 10-nucleotide ssDNA fragment. In earlier NMR studies of the apo-protein, the group showed that the XPF homo-
dimer complex is more stable than the XPF–ERCC1 heterodimer complex (Das et al. 2008). The structure shows that a
positively charged region of one HhH domain interacts with the ssDNA phosphate backbone. The central guanine (G5) is
extruded from the duplex and inserted into a pocket formed by residues from both HhH motifs of XPF (Das et al. 2008;
Tripsianes et al. 2005). This cavity offers a large interaction surface area for the protein with the DNA. The DNA forms a
right-handed structure binding to the protein, which mainly interacts with the ssDNA phosphate backbone (Fig. 14). In ad-
dition, the protein interacts with three bases: thymidine3 (His857), thymidine4 (Ser875, Ile876) and G5 (Leu877, Gly878 and
Asn879). Combined with previous data (Tripsianes et al. 2005) the group proposes a binding model of XPF–ERCC1 to ss/
dsDNA junctions (Das et al. 2012). They modeled the XPF–ERCC1 complex bound to a splayed-arm DNA substrate showing
Fig. 13. (a) Structural domains of the human XPF and ERCC1 proteins. XPF interacts with ERCC1 (residues 670–895) depicted in
green. The inactive helicase domain is depicted in light blue, the nuclease domain in cyan and the HhH2 domain in yellow. ERCC1 inter-
acts with XPA (residues 99–118) depicted in dark blue. The central domain is depicted in green and the HhH2 domain in light green. (b)
Structure of the human XPF–ERCC1 heterodimer (PDB code: 2A1J) (Tsodikov et al. 2005) with ERCC1 depicted in green and XPF
depicted in light blue. (c) Model of the XPF–ERCC1 complex binding to a splayed DNA substrate (depicted in gray). The ERCC1 central
domain and HhH domain are depicted in green. XPF, XPF cleavage site and HhH domain are depicted in light blue.
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that the conserved HhH domain of ERCC1 contacts the phosphate backbone of dsDNA in the minor grove with its two hair-
pins H1 and H2 while the XPF HhH domain stabilizes the ssDNA via interactions with a 5′/3′ polarity (Fig. 13c). The
damaged strand gets cleaved by the catalytic residues of the XPF nuclease domain and the ERCC1 central domain connects
with XPA and ssDNA on the NER complex (de Laat et al. 1998).
8. XPG
XPG (gene called ERCC5) is a single-stranded structure-specific DNA 3′-endonuclease involved in NER. It belongs to the
family of FEN-1 endonucleases (Flap endonuclease) (Lieber, 1997). The human protein consists of 1186 amino acids (133
kDa) (O’Donovan et al. 1994b) and it interacts with several other NER proteins (Fig. 15). Mutations in this gene cause
the XP-G phenotype, characterized by hypersensitivity to UV light and increased susceptibility for skin cancer development
following UV exposure. Furthermore, it can lead to the CS characterized by severe growth defects and mental retardation
(Constantinou et al. 1999). The XPG protein cleaves DNA near junctions of dsDNA to ssDNA with a defined polarity moving
3′–5′ away from the junction. It has been observed that XPG needs a duplex opening of more than five base pairs for efficient
cleavage (Evans et al. 1997a). The protein is known to interact with XPB, XPD, RPA and PCNA (Feltes & Bonatto, 2015; Iyer
et al. 1996). XPG is needed for the proper recruitment of XPF–ERCC1 to the preincision complex. Once the 5′-incision is
made by the XPF–ERCC1 nuclease, XPG becomes fully active (Staresincic et al. 2009). Despite this knowledge, the exact
mechanism of substrate recognition by XPG is still unclear.
The human protein possesses a globular structure like the FEN-1 endonuclease (Hosfield et al. 1998; Hwang et al. 1998b). It
contains an N-terminal domain and an I-region linked by a 600 residue long spacer region (Dunand-Sauthier et al. 2005;
Hohl et al. 2007). The N-terminal and the I-region are evolutionary conserved among similar endonucleases (T4 RNaseH,
Taq Polymerase). The spacer region is not involved in catalysis. It is responsible for proper DNA cleavage and for the recruit-
ment and positioning of XPG to the lesion site (Constantinou et al. 1999; Dunand-Sauthier et al. 2005; He et al. 1995; Thorel
et al. 2004). It is also known to interact with RPA and TFIIH. The protein contains a D1 box (residues 184–210) and a D2 box
(residues 890–984) which are evolutionary conserved (Dunand-Sauthier et al. 2005; Houle & Friedberg, 1999). One cation is
required for the endonuclease activity in the active site. The protein shows a higher affinity for Mn2+ than for Mg2+ and uses
the more abundant one for catalysis (Hohl et al. 2007; Iyer et al. 1996). Two residues in the active site (Glu791 and Asp812)
coordinate the divalent cations (Constantinou et al. 1999) (light blue sticks in Fig. 15). The protein incises flap DNA and
bubbled DNA structures with a defined polarity (Evans et al. 1997b; Hohl et al. 2003; O’Donovan et al. 1994a; Tsutakawa
et al. 2011).
8.1 Crystal structure of the yeast XPG (Rad2) in complex with dsDNA
To understand the mechanism of DNA binding by XPG Mietus et al. (2014) solved in 2014 the crystal structure of the cata-
lytic core of the Saccharomyces cerevisiae homolog of XPG (Rad2-ΔSC, Fig. 16a) in complex with four different DNA sub-
strates. For crystallization a XPG variant missing the mostly disordered spacer residues 111–730 between the two sequence
segments N and I of the nuclease domain was used. The double-stranded oligonucleotides (12–15 bp) were designed with
single-stranded overhangs constructed with one to six adenines or thymidines. In the crystal structure two Rad2 proteins
bind to one DNA substrate with a single-protein molecule covering 13 bp of the double-stranded portion. Rad2 utilizes
Fig. 14. NMR structure of the C-terminal domain of human XPF in complex with an ssDNA fragment (PDB code: 2KN7) (Das et al.
2012). The first XPF (XPF1) protein is depicted in light blue showing the interacting residues with the DNA in yellow. The second XPF
(XPF2) protein is depicted in light blue. The central guanine (G5) is depicted in green.
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three structural domains to recognize the double-stranded portion of the DNA but it does not specifically recognize the single-
stranded portion of the duplex. The structures reveal that the protein recognizes a single 5′-nucleotide of the single-stranded
portion of the DNA and a 3′-phosphate group of the ds/ssDNA junction. The helix two turn helix (H2TH) motif including a
Rad2-specific α-helix 12b and a hydrophobic wedge, which binds the first base pair of the double-stranded portion of the
DNA, is responsible for binding to DNA. The helical arch may assume a different structure in Rad2 because its active site
is more accessible compared with related enzymes such as FEN1 and EXO1 (Mietus et al. 2014). This feature allows the pro-
tein to form a gap and create an exit route from the active site. As expected, the catalytic core of Rad2 is quite comparable with
other flap nucleases (Orans et al. 2011). The protein has an oblong shape with its active site situated in the middle. A twisted
central β-sheet composed of seven strands flanked by α-helices build the central core of the protein (Fig. 16b). Gln37 forms a
hydrogen bond with the base of the cleaved strand and represents an important residue of substrate recognition by Rad2. The
H2TH module is responsible for the key protein–DNA interactions through its Rad2-specific helix α12b and the hydrophobic
wedge contacting the ss/dsDNA junction.
Fig. 16. Crystal structure of the Rad2–DNA complex (PDB code: 4Q0W) (Mietus et al. 2014). (a) Schematic representation of the pro-
tein. The hydrophobic wedge is depicted in green, the helical arch in red, the H2TH domain in light blue and the rest of the crystallized
structure in dark blue. (b) Structure of Rad2 with dsDNA. Same color code as in (a). Calcium is depicted in light green and potassium in
purple. The helix 12b is named as referred by Tsutakawa et al. (2011). The spacer region omitted in the crystal structure is depicted as a
yellow dashed line.
Fig. 15. Schematic representation of human XPG with its different domains and the region interacting with other NER proteins. The D1
box is depicted in light green, the D2 box in green and the 600 aa spacer region in orange. The XPB and XPD interacting region is high-
lighted in purple, RPA interacting region in dark blue and the PCNA interacting region in pink. Glu791 and Asp812 in the active sites
are depicted as light blue bars.
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9. XPV
The repair of lesions by NER is a powerful method to clean the genome from the plethora of lesions that are generated daily.
NER is hence the prime pathway that allows cells to cope with DNA damage. Because lesions can occur at any time in cellular
DNA, even when the NER complex cannot assemble properly, e.g. while the cell is undergoing cell division, a second system
has evolved that allows cells to cope with lesions. This system does not repair lesions but is able to give cells the ability to
tolerate lesions, so that repair can be shifted to later times. This lesion tolerance process (called TLS) requires the action
of special lesion tolerance polymerases. Among them the polymerase ɳ (XPV) is of prime importance, because it provides
tolerance of dinucleotide lesions such as CPDs and cisplatin adducts, which are the prime repair targets for NER. XPV
(Polymerase ɳ) is a Y-family DNA polymerase responsible for TLS enabling replication through bulky DNA adducts like cis-
platin, UV-induced CPDs and 6–4PP as well as acetylaminofluorene adducts and oxidative lesions (like 8-oxo-G) (Alt et al.
2007; Biertumpfel et al. 2010; Haracska et al. 2000; Reissner et al. 2010; Schorr et al. 2010b; Silverstein et al. 2010a, b). The
human protein consists of 713 amino acids with a size of 78 kDa (Masutani et al. 1999a). Indeed, mutation in the XPV gene
leads to just another form of XP called the variant type also associated with a high risk of developing skin cancer (Johnson
et al. 2000; Lehmann et al. 1975; Masutani et al. 1999b). Lesion tolerance, however, has a major drawback. Because the poly-
merases are able to read through lesions they also have a strongly reduced replication fidelity, which gives rise to mutations.
That is why repair is always the first and preferred defense pathway.
9.1 Crystal structure of the yeast XPV (Rad30) protein
Kondratick et al. (2001) solved the crystal structure of the catalytic core (1–513 amino acids) of the S. cerevisiae apo-enzyme
(Fig. 17b). The catalytic core possesses the same bypass activity as the full-length protein (1–632 amino acids). The structure
shows that the polymerase possesses a right-hand shape built up by four domains: thumb, fingers, PAD-domain
(polymerase-associated domain also named ‘little fingers’ (LF)) and the palm domain (Fig. 17a). Characterized by a wide
open and possibly flexible active site, the polymerase is able to replicate over bulky dinucleotide lesions, however, at the
cost of misincorporation and only a low processivity in contrast to high-fidelity polymerases. Because of the helix deforming
action of lesions like intrastrand crosslinks (CPD and 1,2-GG) their bypass by high-fidelity DNA polymerases is impossible.
Being able to bypass cisplatin crosslinks, XPV enables cells to gain resistance against cisplatin-based chemotherapy.
9.2 Crystal structure of the yeast XPV (Rad30) in complex with 1,2-GG cisplatin
Alt et al. (2007) solved the crystal structure of XPV replicating over 1,2-GG containing DNA. This structure provided insights
into the molecular mechanism that allows replication of XPV across strongly distorting DNA lesions. 1,2-GG and 1,3-GTG
cisplatin adducts are formed in a typical cancer therapy with cisplatin. In the structure, XPV accommodates the full 1,2-GG
adduct in its active site where it properly base pairs the 3′ G of the 1,2-GG lesion with a dCTP (Fig. 18). For the nucleotidyl
transfer, the DNA rotates into an active conformation, supported by hydrogen bonding of the temple base to the dCTP. The
bypass of the 3′-dG of 1,2-GG is more efficient and accurate than the bypass of the 5′-dG. In the palm domain, Asp30 and
Asp155 coordinate the divalent cations in the active site and Glu156 is responsible for the catalysis. Glu39 plays a structural
role too, because it maintains the integrity of the fingers domain. Arg73 coordinates the incoming dNTP for the lesion bypass
step and stacks on top of the base moiety. Two magnesium ions are coordinated by the catalytically essential residues.
9.3 Crystal structure of the yeast XPV (Rad30) in complex with the CPD lesion
Silverstein et al. (2010b) determined the crystal structure of yeast Rad30 in complex with a cis–syn T–T dimer lesion. These
authors argue that crystal contacts between the palm and the PAD domain of two neighboring proteins in the crystal lattice
influence the binding of the protein to the DNA. The group performed a double-mutation (K140A, S144W) to eliminate these
contacts, and indeed crystals were obtained with a different space group. Deeper analysis of the structure shows that the finger
domain is a little more closed but the situation in the active site is almost unchanged compared with the yeast structure (Alt
et al. 2007). Figure 19 shows the XPV structure with its different domains, the containing T–T dimer and the incoming dATP.
Again the large active site accommodates the dinucleotide lesion very similar to what was already shown by Alt et al. for the
cisplatin lesion. The 3′T of the dimer interacts with the incoming dATP by Watson–Crick hydrogen bonding. The 5′T of the
lesion builds van der Waals contacts with Met74 and Arg73 of the finger domain. The active site residues of the palm domain
(Asp30, Asp155 and Glu156) catalyze the nucleotidyl transfer reaction. By mutational analysis and biochemical assays
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9.4 Crystal structure of the human XPV in complex with the CPD lesion
Biertumpfel et al. (2010) reported the crystal structure of the catalytic core (residues 1–432) of human polymerase ɳ at four
consecutive steps during DNA synthesis through cis–syn CPD lesion (Fig. 20b). They could show on a molecular level how
human XPV efficiently bypasses the lesion in TLS. Human XPV, similar to its yeast homolog, consists of four domains: palm,
PAD (little fingers), thumb and the fingers (Fig. 20a). The active site is situated in the palm domain and the DNA is bound
between the thumb and the finger domains. Acting as a molecular splint the polymerase keeps the damaged DNA straight and
rigid in its B-form conformation in contrast to the bent and unwound structures of CPD containing DNA with other repair
enzymes or alone. The β-strand in the little finger is nearly parallel to the template strand and hydrogen bonding of the main
chain amides to the phosphate supports this conformation. Again, the most prominent feature is the large active site of the
protein already reported by Alt et al. (2007), which is able to accommodate two bases of the template strand instead of one.
The 3′ thymine of CPD is base paired with the incoming dATP, while the 5′ thymine is turned and moved closer to the finger
domain which leads to tighter interactions than the ones observed with undamaged DNA. Furthermore, the two residues
Arg61 and Glu38 that are conserved among the XPV homologs create specific hydrogen bonds with the incoming dATP
and the CPD lesion. Again, the human XPV shows a more closed finger domain, which contacts the replicating base pair
more intensively. Based on all these structures we can therefore assume that the finger domain is quite flexible and that
the more closed structure is the conformation the protein assumes in the processive mode.
Fig. 18. Crystal structure of Rad30 in complex with 1,2-GG cisplatin adduct (PDB code: 2R8 K) (Alt et al. 2007). Rad30 has right-hand
structure containing four domains: palm (violet), thumb (cyan), finger domain (dark blue) and the additional PAD domain (green) which
is unique for Y-family polymerases. The cisplatin adduct is depicted in pink, the dCTP in yellow and the two metal ions in green.
Fig. 17. (a) Structural domains of yeast XPV (Rad30) (Silverstein et al. 2010b). (b) Structure of the catalytic domain of S. cerevisiae XPV
showing the four domains (PDB code: 1JIH) (Trincao et al. 2001). The fingers domain is depicted in dark blue, the PAD domain in
green, the ThM in cyan and the palm domain in purple.
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Further crystal structures of human and yeast XPV could be resolved with different DNA damages such as 1,3-GTG cisplatin
or 8-oxoG (Reissner et al. 2010; Silverstein et al. 2010a). Schorr & Carell (2010a) crystallized the S. cerevisiae XPV (Rad30)
with an AAF-dG lesion and they proposed a model for lesion bypass. In vivo experiments show that Pol η indeed replicates
through acetylated aromatic amine lesions such as AAF-dG (Bresson & Fuchs, 2002). In vitro studies revealed that both
human and yeast XPV base pair the AAF-dG lesion correctly with dC (Bresson & Fuchs, 2002; Livneh, 2001; Masutani
et al. 2000; Matsuda et al. 2000) and are able to catalyze the extension from the lesion, however, with reduced efficiency
(Masutani et al. 2000). In addition, XPV also incorporates a correct dCTP opposite the N2-AAF-dG adduct (Yasui et al.
2004). It has also been shown that XPV is responsible for the occurrence of frameshift mutations in response to the presence
of aromatic amine lesions during replication (Bresson & Fuchs, 2002; Cordonnier et al. 1999).
10. Conclusion
In this review, we presented the most recent eukaryotic structures of the XP proteins in complex with their DNA substrate.
When no co-crystal structures with the DNA substrate were obtained we discussed the models of protein–DNA interaction
Fig. 20. (a) Schematic representation of human XPV showing the different domains. The finger domain is depicted in purple, the palm
domain in dark blue, the ThM in green and PAD domain (little fingers) in cyan. (b) Crystal structure of human XPV in complex with
CPD damaged DNA (PDB code: 3MR3) (Biertumpfel et al. 2010). Same color code as in (a). The CPD lesion is shown in orange and the
dAMPNPP (2′-deoxy-adenosine-5′-[(α,β)-imido]-triphosphate) is shown in yellow. The two Mg2+ ions of the active site are depicted in red.
Fig. 19. Structure of Rad30 with a CPD lesion. The cis–syn T–T dimer is depicted in orange and the incoming dATP is shown in yellow
(PDB code: 3MFI) (Silverstein et al. 2010b). The four domains are depicted with different colors: fingers (blue), palm (violet), PAD
(green) and thumb (light blue). The two Mg2+ ions in the active site are colored in red.
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that were proposed. All these structures led to a dramatic increase of our understanding of the role of the individual XP pro-
teins in DNA damage repair and tolerance. The structures allow to determine binding partner regions and to elucidate on a
molecular level the interaction between the proteins and their DNA substrates. Now, further studies have to be done in order
to better understand the correlation between genetic defects and the role of the various XP proteins in NER and TLS. We also
need further human structural information and most importantly structures of the XP proteins in functional complexes with
the other involved NER proteins. This would allow deciphering of the protein–protein interactions on the DNA damage site
and it may shed light on the correlation to genetic disorders. Understanding the mechanism of NER and TLS in correlation
with human genetic disorders unveils the biological basis for oncogenesis and aging. Last but not least, proteomics data are
needed to uncover the functional relations of the proteins involved in replication, transcription and repair.
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